Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Trans Chem is a leading Australian distributor of specialty chemicals and ingredients, primarily serving the pharmaceutical, nutraceutical, and veterinary industries. Founded in 1994 and headquartered in Sydney, the company specializes in the sourcing and supply of Active Pharmaceutical Ingredients (APIs), vitamins, amino acids, and fine chemicals. Trans Chem provides comprehensive services including technical support, regulatory assistance, and supply chain management to manufacturers across the Oceania region. In November 2022, the company was acquired by Brenntag, the global market leader in chemicals and ingredients distribution, to bolster Brenntag's Life Science presence in Australia and New Zealand. The acquisition integrated Trans Chem's extensive product portfolio and local market expertise into Brenntag's global network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Trans Chem.